Healthcare Associated Infections (HAI)

Latest News

FDA Advisory Committee Recommends Rezafungin for Candidemia and Invasive Candidiasis
FDA Advisory Committee Recommends Rezafungin for Candidemia and Invasive Candidiasis

January 25th 2023

If approved on its March PDUFA date, rezafungin could be the first new Candida treatment option in over a decade.

IntelliSep Becomes First Sepsis Diagnostic Tool to Receive FDA Clearance
IntelliSep Becomes First Sepsis Diagnostic Tool to Receive FDA Clearance

January 18th 2023

What Makes Fecal Microbiota Transplant an Effective C Difficile Cure?
What Makes Fecal Microbiota Transplant an Effective C Difficile Cure?

January 16th 2023

Enterococcus Coinfection Enhances C Difficile Infection Severity
Enterococcus Coinfection Enhances C Difficile Infection Severity

December 5th 2022

C difficile Awareness Month: Breakthroughs and Setbacks
C difficile Awareness Month: Breakthroughs and Setbacks

November 25th 2022

Video Series
Video Interviews
Podcasts

More News

© 2023 MJH Life Sciences

All rights reserved.